Hyperhomocysteinemia potentiates hyperglycemia-induced inflammatory monocyte differentiation and atherosclerosis

Hyperhomocysteinemia (HHcy) is associated with increased diabetic cardiovascular diseases. However, the role of HHcy in atherogenesis associated with hyperglycemia (HG) remains unknown. To examine the role and mechanisms by which HHcy accelerates HG-induced atherosclerosis, we established an atheros...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2014-12, Vol.63 (12), p.4275-4290
Hauptverfasser: Fang, Pu, Zhang, Daqing, Cheng, Zhongjian, Yan, Chenghui, Jiang, Xiaohua, Kruger, Warren D, Meng, Shu, Arning, Erland, Bottiglieri, Teodoro, Choi, Eric T, Han, Yaling, Yang, Xiao-Feng, Wang, Hong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4290
container_issue 12
container_start_page 4275
container_title Diabetes (New York, N.Y.)
container_volume 63
creator Fang, Pu
Zhang, Daqing
Cheng, Zhongjian
Yan, Chenghui
Jiang, Xiaohua
Kruger, Warren D
Meng, Shu
Arning, Erland
Bottiglieri, Teodoro
Choi, Eric T
Han, Yaling
Yang, Xiao-Feng
Wang, Hong
description Hyperhomocysteinemia (HHcy) is associated with increased diabetic cardiovascular diseases. However, the role of HHcy in atherogenesis associated with hyperglycemia (HG) remains unknown. To examine the role and mechanisms by which HHcy accelerates HG-induced atherosclerosis, we established an atherosclerosis-susceptible HHcy and HG mouse model. HHcy was established in mice deficient in cystathionine β-synthase (Cbs) in which the homocysteine (Hcy) level could be lowered by inducing transgenic human CBS (Tg-hCBS) using Zn supplementation. HG was induced by streptozotocin injection. Atherosclerosis was induced by crossing Tg-hCBS Cbs mice with apolipoprotein E-deficient (ApoE(-/-)) mice and feeding them a high-fat diet for 2 weeks. We demonstrated that HHcy and HG accelerated atherosclerosis and increased lesion monocytes (MCs) and macrophages (MØs) and further increased inflammatory MC and MØ levels in peripheral tissues. Furthermore, Hcy-lowering reversed circulating mononuclear cells, MC, and inflammatory MC and MC-derived MØ levels. In addition, inflammatory MC correlated positively with plasma Hcy levels and negatively with plasma s-adenosylmethionine-to-s-adenosylhomocysteine ratios. Finally, l-Hcy and d-glucose promoted inflammatory MC differentiation in primary mouse splenocytes, which was reversed by adenoviral DNA methyltransferase-1. HHcy and HG, individually and synergistically, accelerated atherosclerosis and inflammatory MC and MØ differentiation, at least in part, via DNA hypomethylation.
doi_str_mv 10.2337/db14-0809
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4237991</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1832245413</sourcerecordid><originalsourceid>FETCH-LOGICAL-c502t-72b0d459adb1aab184b751520abb35375fd5e290543595b16c790df9c1fe5db13</originalsourceid><addsrcrecordid>eNqFkU9rFTEUxYMo9rW68AvIgBtdTHvz72WyEaSoLRTcVHAXMkmmL2UmGZNMYb69GV4t6kYCyeL-zsm99yD0BsM5oVRc2B6zFjqQz9AOSypbSsSP52gHgEmLhRQn6DTnewDY1_MSnRAO0GHBdmi-WmeXDnGKZs3F-eAmr5s5FheK18Xl5rABd-Nqtkrrg12Ms40Pw6inSZeY1maKocqLa6wfBpeOUh9Do4NtdDm4FLMZt9vnV-jFoMfsXj--Z-j7l8-3l1ftzbev15efblrDgZRWkB4s41LX2bTuccd6wTEnoPuecir4YLkjEjijXPIe742QYAdp8OB41dAz9PHoOy_95KypTSU9qjn5SadVRe3V35XgD-ouPihGqJByM3j_aJDiz8XloiafjRtHHVxcssIdJYRxhun_0T0RIKjsuoq--we9j0sKdROVqh-LGher1IcjZerOcnLDU98Y1Ba52iJXW-SVffvnoE_k74zpL1RGqos</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1637971794</pqid></control><display><type>article</type><title>Hyperhomocysteinemia potentiates hyperglycemia-induced inflammatory monocyte differentiation and atherosclerosis</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Journals@Ovid Complete</source><creator>Fang, Pu ; Zhang, Daqing ; Cheng, Zhongjian ; Yan, Chenghui ; Jiang, Xiaohua ; Kruger, Warren D ; Meng, Shu ; Arning, Erland ; Bottiglieri, Teodoro ; Choi, Eric T ; Han, Yaling ; Yang, Xiao-Feng ; Wang, Hong</creator><creatorcontrib>Fang, Pu ; Zhang, Daqing ; Cheng, Zhongjian ; Yan, Chenghui ; Jiang, Xiaohua ; Kruger, Warren D ; Meng, Shu ; Arning, Erland ; Bottiglieri, Teodoro ; Choi, Eric T ; Han, Yaling ; Yang, Xiao-Feng ; Wang, Hong</creatorcontrib><description>Hyperhomocysteinemia (HHcy) is associated with increased diabetic cardiovascular diseases. However, the role of HHcy in atherogenesis associated with hyperglycemia (HG) remains unknown. To examine the role and mechanisms by which HHcy accelerates HG-induced atherosclerosis, we established an atherosclerosis-susceptible HHcy and HG mouse model. HHcy was established in mice deficient in cystathionine β-synthase (Cbs) in which the homocysteine (Hcy) level could be lowered by inducing transgenic human CBS (Tg-hCBS) using Zn supplementation. HG was induced by streptozotocin injection. Atherosclerosis was induced by crossing Tg-hCBS Cbs mice with apolipoprotein E-deficient (ApoE(-/-)) mice and feeding them a high-fat diet for 2 weeks. We demonstrated that HHcy and HG accelerated atherosclerosis and increased lesion monocytes (MCs) and macrophages (MØs) and further increased inflammatory MC and MØ levels in peripheral tissues. Furthermore, Hcy-lowering reversed circulating mononuclear cells, MC, and inflammatory MC and MC-derived MØ levels. In addition, inflammatory MC correlated positively with plasma Hcy levels and negatively with plasma s-adenosylmethionine-to-s-adenosylhomocysteine ratios. Finally, l-Hcy and d-glucose promoted inflammatory MC differentiation in primary mouse splenocytes, which was reversed by adenoviral DNA methyltransferase-1. HHcy and HG, individually and synergistically, accelerated atherosclerosis and inflammatory MC and MØ differentiation, at least in part, via DNA hypomethylation.</description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/db14-0809</identifier><identifier>PMID: 25008174</identifier><identifier>CODEN: DIAEAZ</identifier><language>eng</language><publisher>United States: American Diabetes Association</publisher><subject>Animals ; Apolipoproteins E - genetics ; Atherosclerosis ; Atherosclerosis - complications ; Atherosclerosis - immunology ; Cardiovascular disease ; Cell Differentiation - immunology ; Complications ; Correlation analysis ; Cystathionine beta-Synthase - genetics ; Deoxyribonucleic acid ; Diet, High-Fat - adverse effects ; Disease Models, Animal ; DNA ; Humans ; Hyperglycemia - complications ; Hyperglycemia - immunology ; Hyperhomocysteinemia - complications ; Hyperhomocysteinemia - immunology ; Inflammation - immunology ; Macrophages - immunology ; Mice ; Mice, Transgenic ; Monocytes - immunology ; Rodents</subject><ispartof>Diabetes (New York, N.Y.), 2014-12, Vol.63 (12), p.4275-4290</ispartof><rights>2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.</rights><rights>Copyright American Diabetes Association Dec 2014</rights><rights>2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c502t-72b0d459adb1aab184b751520abb35375fd5e290543595b16c790df9c1fe5db13</citedby><cites>FETCH-LOGICAL-c502t-72b0d459adb1aab184b751520abb35375fd5e290543595b16c790df9c1fe5db13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237991/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237991/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25008174$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fang, Pu</creatorcontrib><creatorcontrib>Zhang, Daqing</creatorcontrib><creatorcontrib>Cheng, Zhongjian</creatorcontrib><creatorcontrib>Yan, Chenghui</creatorcontrib><creatorcontrib>Jiang, Xiaohua</creatorcontrib><creatorcontrib>Kruger, Warren D</creatorcontrib><creatorcontrib>Meng, Shu</creatorcontrib><creatorcontrib>Arning, Erland</creatorcontrib><creatorcontrib>Bottiglieri, Teodoro</creatorcontrib><creatorcontrib>Choi, Eric T</creatorcontrib><creatorcontrib>Han, Yaling</creatorcontrib><creatorcontrib>Yang, Xiao-Feng</creatorcontrib><creatorcontrib>Wang, Hong</creatorcontrib><title>Hyperhomocysteinemia potentiates hyperglycemia-induced inflammatory monocyte differentiation and atherosclerosis</title><title>Diabetes (New York, N.Y.)</title><addtitle>Diabetes</addtitle><description>Hyperhomocysteinemia (HHcy) is associated with increased diabetic cardiovascular diseases. However, the role of HHcy in atherogenesis associated with hyperglycemia (HG) remains unknown. To examine the role and mechanisms by which HHcy accelerates HG-induced atherosclerosis, we established an atherosclerosis-susceptible HHcy and HG mouse model. HHcy was established in mice deficient in cystathionine β-synthase (Cbs) in which the homocysteine (Hcy) level could be lowered by inducing transgenic human CBS (Tg-hCBS) using Zn supplementation. HG was induced by streptozotocin injection. Atherosclerosis was induced by crossing Tg-hCBS Cbs mice with apolipoprotein E-deficient (ApoE(-/-)) mice and feeding them a high-fat diet for 2 weeks. We demonstrated that HHcy and HG accelerated atherosclerosis and increased lesion monocytes (MCs) and macrophages (MØs) and further increased inflammatory MC and MØ levels in peripheral tissues. Furthermore, Hcy-lowering reversed circulating mononuclear cells, MC, and inflammatory MC and MC-derived MØ levels. In addition, inflammatory MC correlated positively with plasma Hcy levels and negatively with plasma s-adenosylmethionine-to-s-adenosylhomocysteine ratios. Finally, l-Hcy and d-glucose promoted inflammatory MC differentiation in primary mouse splenocytes, which was reversed by adenoviral DNA methyltransferase-1. HHcy and HG, individually and synergistically, accelerated atherosclerosis and inflammatory MC and MØ differentiation, at least in part, via DNA hypomethylation.</description><subject>Animals</subject><subject>Apolipoproteins E - genetics</subject><subject>Atherosclerosis</subject><subject>Atherosclerosis - complications</subject><subject>Atherosclerosis - immunology</subject><subject>Cardiovascular disease</subject><subject>Cell Differentiation - immunology</subject><subject>Complications</subject><subject>Correlation analysis</subject><subject>Cystathionine beta-Synthase - genetics</subject><subject>Deoxyribonucleic acid</subject><subject>Diet, High-Fat - adverse effects</subject><subject>Disease Models, Animal</subject><subject>DNA</subject><subject>Humans</subject><subject>Hyperglycemia - complications</subject><subject>Hyperglycemia - immunology</subject><subject>Hyperhomocysteinemia - complications</subject><subject>Hyperhomocysteinemia - immunology</subject><subject>Inflammation - immunology</subject><subject>Macrophages - immunology</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Monocytes - immunology</subject><subject>Rodents</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU9rFTEUxYMo9rW68AvIgBtdTHvz72WyEaSoLRTcVHAXMkmmL2UmGZNMYb69GV4t6kYCyeL-zsm99yD0BsM5oVRc2B6zFjqQz9AOSypbSsSP52gHgEmLhRQn6DTnewDY1_MSnRAO0GHBdmi-WmeXDnGKZs3F-eAmr5s5FheK18Xl5rABd-Nqtkrrg12Ms40Pw6inSZeY1maKocqLa6wfBpeOUh9Do4NtdDm4FLMZt9vnV-jFoMfsXj--Z-j7l8-3l1ftzbev15efblrDgZRWkB4s41LX2bTuccd6wTEnoPuecir4YLkjEjijXPIe742QYAdp8OB41dAz9PHoOy_95KypTSU9qjn5SadVRe3V35XgD-ouPihGqJByM3j_aJDiz8XloiafjRtHHVxcssIdJYRxhun_0T0RIKjsuoq--we9j0sKdROVqh-LGher1IcjZerOcnLDU98Y1Ba52iJXW-SVffvnoE_k74zpL1RGqos</recordid><startdate>20141201</startdate><enddate>20141201</enddate><creator>Fang, Pu</creator><creator>Zhang, Daqing</creator><creator>Cheng, Zhongjian</creator><creator>Yan, Chenghui</creator><creator>Jiang, Xiaohua</creator><creator>Kruger, Warren D</creator><creator>Meng, Shu</creator><creator>Arning, Erland</creator><creator>Bottiglieri, Teodoro</creator><creator>Choi, Eric T</creator><creator>Han, Yaling</creator><creator>Yang, Xiao-Feng</creator><creator>Wang, Hong</creator><general>American Diabetes Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>20141201</creationdate><title>Hyperhomocysteinemia potentiates hyperglycemia-induced inflammatory monocyte differentiation and atherosclerosis</title><author>Fang, Pu ; Zhang, Daqing ; Cheng, Zhongjian ; Yan, Chenghui ; Jiang, Xiaohua ; Kruger, Warren D ; Meng, Shu ; Arning, Erland ; Bottiglieri, Teodoro ; Choi, Eric T ; Han, Yaling ; Yang, Xiao-Feng ; Wang, Hong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c502t-72b0d459adb1aab184b751520abb35375fd5e290543595b16c790df9c1fe5db13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Apolipoproteins E - genetics</topic><topic>Atherosclerosis</topic><topic>Atherosclerosis - complications</topic><topic>Atherosclerosis - immunology</topic><topic>Cardiovascular disease</topic><topic>Cell Differentiation - immunology</topic><topic>Complications</topic><topic>Correlation analysis</topic><topic>Cystathionine beta-Synthase - genetics</topic><topic>Deoxyribonucleic acid</topic><topic>Diet, High-Fat - adverse effects</topic><topic>Disease Models, Animal</topic><topic>DNA</topic><topic>Humans</topic><topic>Hyperglycemia - complications</topic><topic>Hyperglycemia - immunology</topic><topic>Hyperhomocysteinemia - complications</topic><topic>Hyperhomocysteinemia - immunology</topic><topic>Inflammation - immunology</topic><topic>Macrophages - immunology</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Monocytes - immunology</topic><topic>Rodents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fang, Pu</creatorcontrib><creatorcontrib>Zhang, Daqing</creatorcontrib><creatorcontrib>Cheng, Zhongjian</creatorcontrib><creatorcontrib>Yan, Chenghui</creatorcontrib><creatorcontrib>Jiang, Xiaohua</creatorcontrib><creatorcontrib>Kruger, Warren D</creatorcontrib><creatorcontrib>Meng, Shu</creatorcontrib><creatorcontrib>Arning, Erland</creatorcontrib><creatorcontrib>Bottiglieri, Teodoro</creatorcontrib><creatorcontrib>Choi, Eric T</creatorcontrib><creatorcontrib>Han, Yaling</creatorcontrib><creatorcontrib>Yang, Xiao-Feng</creatorcontrib><creatorcontrib>Wang, Hong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fang, Pu</au><au>Zhang, Daqing</au><au>Cheng, Zhongjian</au><au>Yan, Chenghui</au><au>Jiang, Xiaohua</au><au>Kruger, Warren D</au><au>Meng, Shu</au><au>Arning, Erland</au><au>Bottiglieri, Teodoro</au><au>Choi, Eric T</au><au>Han, Yaling</au><au>Yang, Xiao-Feng</au><au>Wang, Hong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hyperhomocysteinemia potentiates hyperglycemia-induced inflammatory monocyte differentiation and atherosclerosis</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><addtitle>Diabetes</addtitle><date>2014-12-01</date><risdate>2014</risdate><volume>63</volume><issue>12</issue><spage>4275</spage><epage>4290</epage><pages>4275-4290</pages><issn>0012-1797</issn><eissn>1939-327X</eissn><coden>DIAEAZ</coden><abstract>Hyperhomocysteinemia (HHcy) is associated with increased diabetic cardiovascular diseases. However, the role of HHcy in atherogenesis associated with hyperglycemia (HG) remains unknown. To examine the role and mechanisms by which HHcy accelerates HG-induced atherosclerosis, we established an atherosclerosis-susceptible HHcy and HG mouse model. HHcy was established in mice deficient in cystathionine β-synthase (Cbs) in which the homocysteine (Hcy) level could be lowered by inducing transgenic human CBS (Tg-hCBS) using Zn supplementation. HG was induced by streptozotocin injection. Atherosclerosis was induced by crossing Tg-hCBS Cbs mice with apolipoprotein E-deficient (ApoE(-/-)) mice and feeding them a high-fat diet for 2 weeks. We demonstrated that HHcy and HG accelerated atherosclerosis and increased lesion monocytes (MCs) and macrophages (MØs) and further increased inflammatory MC and MØ levels in peripheral tissues. Furthermore, Hcy-lowering reversed circulating mononuclear cells, MC, and inflammatory MC and MC-derived MØ levels. In addition, inflammatory MC correlated positively with plasma Hcy levels and negatively with plasma s-adenosylmethionine-to-s-adenosylhomocysteine ratios. Finally, l-Hcy and d-glucose promoted inflammatory MC differentiation in primary mouse splenocytes, which was reversed by adenoviral DNA methyltransferase-1. HHcy and HG, individually and synergistically, accelerated atherosclerosis and inflammatory MC and MØ differentiation, at least in part, via DNA hypomethylation.</abstract><cop>United States</cop><pub>American Diabetes Association</pub><pmid>25008174</pmid><doi>10.2337/db14-0809</doi><tpages>16</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0012-1797
ispartof Diabetes (New York, N.Y.), 2014-12, Vol.63 (12), p.4275-4290
issn 0012-1797
1939-327X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4237991
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Journals@Ovid Complete
subjects Animals
Apolipoproteins E - genetics
Atherosclerosis
Atherosclerosis - complications
Atherosclerosis - immunology
Cardiovascular disease
Cell Differentiation - immunology
Complications
Correlation analysis
Cystathionine beta-Synthase - genetics
Deoxyribonucleic acid
Diet, High-Fat - adverse effects
Disease Models, Animal
DNA
Humans
Hyperglycemia - complications
Hyperglycemia - immunology
Hyperhomocysteinemia - complications
Hyperhomocysteinemia - immunology
Inflammation - immunology
Macrophages - immunology
Mice
Mice, Transgenic
Monocytes - immunology
Rodents
title Hyperhomocysteinemia potentiates hyperglycemia-induced inflammatory monocyte differentiation and atherosclerosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T15%3A27%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hyperhomocysteinemia%20potentiates%20hyperglycemia-induced%20inflammatory%20monocyte%20differentiation%20and%20atherosclerosis&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=Fang,%20Pu&rft.date=2014-12-01&rft.volume=63&rft.issue=12&rft.spage=4275&rft.epage=4290&rft.pages=4275-4290&rft.issn=0012-1797&rft.eissn=1939-327X&rft.coden=DIAEAZ&rft_id=info:doi/10.2337/db14-0809&rft_dat=%3Cproquest_pubme%3E1832245413%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1637971794&rft_id=info:pmid/25008174&rfr_iscdi=true